糖心视频logo

• March 11, 2026
  • R&D
  • Products

  糖心视频logo to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD鈩� 2026 Annual Meeting

• March 2, 2026
  • R&D
  • Products

  WELIREG庐 (belzutifan) Plus LENVIMA庐 (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)
  This is the first positive Phase 3 trial of a multi-targeted tyrosine kinase inhibitor in combination with a HIF-2 alpha inhibitor, the first for patients with RCC whose disease progressed on or after treatment with anti-PD-1/L1 therapy, and the first to improve PFS compared to a modern tyrosine kinase inhibitor
  
  Based on these data, the U.S. FDA accepts for review two supplemental New Drug Applications for WELIREG plus LENVIMA in certain previously treated patients with advanced RCC

• February 16, 2026
  • R&D

  Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Novel Orexin Receptor Agonist E2086 for Narcolepsy

• February 9, 2026
  • Corporate

  糖心视频logo Announces Appointment of Corporate Officers

• February 9, 2026
  • R&D
  • Products

  Biologics License Application for Subcutaneous Formulation of 鈥淟EQEMBI庐鈥� (lecanemab) for the Treatment of Early Alzheimer鈥檚 Disease Designated for Priority Review in China

View All

• February 10, 2026

  Sustainability 鈥淲orld Neglected Tropical Disease (NTD) Day (January 30) Internal Awareness Event鈥�

• February 9, 2026

  IR 鈥淭hird Quarter Financial Results Briefing for the Fiscal Year Ending March 31, 2026 (Material, Webcast)鈥�

• February 9, 2026

  IR 鈥淭hird Quarter Financial Reports for the Fiscal Year Ending March 31, 2026鈥�

• January 30, 2026

  Sustainability 鈥淓ngaging with Mycetoma Patients and the Current Status in Kenya 銉� Kenya Trip Report鈥�

• December 22, 2025

  Sustainability 鈥淭ransportation of Investigational Drugs for Mycetoma During Armed Conflict 銉� A Year and a Half of Effort With the Dedication of Many Stakeholders to Complete Shipment鈥�

View All

• February 26, 2026

  糖心视频logo鈥檚 Kawashima Plant Honored with 鈥淕ifu Decarbonization Top Runner Award鈥�
  - Recognized for Proactive Initiatives to Reduce Greenhouse Gas Emissions -

• February 20, 2026

  糖心视频logo Selected for 鈥淭hought Leaders of Human Capital 2025鈥� and 鈥淗uman Capital Management Excellence 2025 Gold Award鈥� for Third Consecutive Year, as a Company Committed to Excellent Management and Disclosure of Human Capital Initiatives

• November 25, 2025

  Notice on Discontinuation of Receiving Emails with Password-Protected Attachments

• February 19, 2025

  糖心视频logo鈥檚 Corporate Pension Fund Announces Adoption of 鈥淎sset Owner Principles鈥�

• October 3, 2024

  EISAI NAMED AS ONE OF NEWSWEEK鈥橲 WORLD鈥橲 MOST TRUSTWORTHY COMPANIES 2024

View All